Amphastar Pharmaceuticals (AMPH) Change in Taxes (2016 - 2017)

Amphastar Pharmaceuticals has reported Change in Taxes over the past 5 years, most recently at -$2.5 million for Q3 2017.

  • For Q3 2017, Change in Taxes fell 351.29% year-over-year to -$2.5 million; the TTM value through Sep 2017 reached -$5.8 million, down 236.88%, while the annual FY2015 figure was -$92000.0, 116.46% down from the prior year.
  • Change in Taxes for Q3 2017 was -$2.5 million at Amphastar Pharmaceuticals, up from -$3.2 million in the prior quarter.
  • Over five years, Change in Taxes peaked at $6.0 million in Q4 2014 and troughed at -$5.4 million in Q3 2014.
  • A 5-year average of -$314500.0 and a median of -$193500.0 in 2015 define the central range for Change in Taxes.
  • Biggest five-year swings in Change in Taxes: soared 15137.5% in 2014 and later crashed 351.29% in 2017.
  • Year by year, Change in Taxes stood at -$40000.0 in 2013, then soared by 15137.5% to $6.0 million in 2014, then tumbled by 83.52% to $991000.0 in 2015, then crashed by 154.89% to -$544000.0 in 2016, then crashed by 351.29% to -$2.5 million in 2017.
  • Business Quant data shows Change in Taxes for AMPH at -$2.5 million in Q3 2017, -$3.2 million in Q2 2017, and $394000.0 in Q1 2017.